Dr Christine Carrington has over twenty years’ experience of working in the pharmaceutical development industry, mostly in virtual, start-up and small biotech companies. She graduated with a BSc from Birmingham University, gained a PhD in Biochemistry and Cell Biology from Reading University, and followed this with ten years’ academic research at Washington State University and Cambridge University.
Christine then moved to a small biotech company, which subsequently became part of Novartis Pharma, initially as head of a research group and subsequently as Unit Head of Product Development. In 2001, she joined Alizyme Therapeutics Ltd, a virtual pharmaceutical company, and was responsible for all aspects of the development programme for one of Alizyme’s key products, including preliminary research, manufacturing, non-clinical studies, regulatory submissions and clinical studies.
She also has experience in due diligence, out-licensing and contract negotiations. In 2010, Christine became a freelance consultant (Luncia Consulting and Boyd Consultants), mainly working with European and North American companies in the early phases of developing gene based medicines.
This is some default text for the related content right-hand side column. Replace/Delete the text and/or drag and drop related content features into this are. Three features are automatically inserted (site tools, related page, related news) but can be de-activated by using the metadata for the page.